Literature DB >> 3088292

Lupus anticoagulant in the acquired immunodeficiency syndrome.

E J Bloom, D I Abrams, G Rodgers.   

Abstract

Prolongation of partial thromboplastin time was noted in patients with acquired immunodeficiency syndrome (AIDS) who were admitted to the hospital for diagnosis of opportunistic infection. As biopsy procedures were often indicated, detailed investigation of the abnormal coagulation study was performed in four patients. Results confirmed the presence of a lupus anticoagulant. Partial thromboplastin times of 34 consecutive subsequent patients hospitalized with the diagnosis of AIDS-associated opportunistic infection were recorded; prolongation was noted in 24 of these. None of these 38 patients exhibited clinical evidence of bleeding. One patient had a confirmed thrombotic episode. Prolonged partial thromboplastin time is a common finding in hospitalized patients with AIDS and opportunistic infection. If no clinical history of unusual bleeding is noted, the lupus anticoagulant should be suspected. Many patients with AIDS require invasive procedures for disease management; the lupus anticoagulant, an in vitro phenomenon, should not prevent these studies.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3088292

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  23 in total

Review 1.  Antiphospholipid antibodies and infections.

Authors:  R A Asherson; R Cervera
Journal:  Ann Rheum Dis       Date:  2003-05       Impact factor: 19.103

Review 2.  Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients.

Authors:  R Cervera; R A Asherson; M L Acevedo; J A Gómez-Puerta; G Espinosa; G De La Red; V Gil; M Ramos-Casals; M García-Carrasco; M Ingelmo; J Font
Journal:  Ann Rheum Dis       Date:  2004-10       Impact factor: 19.103

3.  Anticardiolipin antibodies in drug addicted patients with AIDS.

Authors:  J Rivera; I Monteagudo; J Lopez-Longo; E Maldonado; L Carreño
Journal:  Ann Rheum Dis       Date:  1991-05       Impact factor: 19.103

4.  Anticardiolipin antibodies and acquired immunodeficiency syndrome: prognostic marker or association with HIV infection?

Authors:  J Coll Daroca; J Gutiérrez-Cebollada; H Yazbeck; A Bergés; J Rubiés-Prat
Journal:  Infection       Date:  1992 May-Jun       Impact factor: 3.553

Review 5.  Review: thromboses among HIV-infected patients during the highly active antiretroviral therapy era.

Authors:  Nancy F Crum-Cianflone; Jhamillia Weekes; Mary Bavaro
Journal:  AIDS Patient Care STDS       Date:  2008-10       Impact factor: 5.078

6.  Hairy cell leukemia and multiple autoimmune manifestations in a human immunodeficiency virus-infected patient.

Authors:  V R Arruda; J M Bizzacchi; I L Metze
Journal:  Ann Hematol       Date:  1993-06       Impact factor: 3.673

7.  Pulmonary Embolism Mimicking Pneumonia in a HIV Patient.

Authors:  Vivek Nagaraja; Joel A Terriquez; Hemanth Gavini; Lokesh Jha; Stephen A Klotz
Journal:  Case Rep Med       Date:  2010-06-14

Review 8.  HIV-mediated B-lymphocyte activation and lymphomagenesis.

Authors:  J G Monroe; L E Silberstein
Journal:  J Clin Immunol       Date:  1995-03       Impact factor: 8.317

Review 9.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

10.  Different clinical presentations of a lupus anticoagulant in the same family.

Authors:  R M Jolidon; H Knecht; L Humair; A de Torrente
Journal:  Klin Wochenschr       Date:  1991-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.